Latest News

STAT Plus: Watch: In a heated debate in Washington, key players spar over drug pricing policies

WASHINGTON — Sparks flew between a patient advocate and a drug industry representative. The middlemen and the manufacturers reached a strained detente. Statistics were offered and disputed, as were policy options both controversial and staid.

Watch the video of our panel, where STAT Washington editor Erin Mershon and Washington correspondent Ike Swetlitz facilitated a wide-ranging discussion between representatives of some of the powerful players in the drug pricing world of Washington. Panelists at the Thursday event included Kristin Bass, senior vice president of policy and federal affairs at the PBM trade group PCMA; Jenny Bryant senior vice president of policy and research at the manufacturer trade group PhRMA; Jane Horvath, a consultant for Horvath Health Policy; and David Mitchell, president of the patient advocacy group Patients for Affordable Drugs.

Source link

Related posts

STAT Plus: Up and down the ladder: The latest comings and goings


Children's NICU slashes unintended extubation rates by 60% over 10 years


Georgia City Pledges To Test Air for Toxic Gas


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy